Cell Transplantation

Last updated

Related Research Articles

<span class="mw-page-title-main">Everolimus</span> Chemical compound

Everolimus, sold under the brand name Afinitor among others, is a medication used as an immunosuppressant to prevent rejection of organ transplants and as a targeted therapy in the treatment of renal cell cancer and other tumours.

<span class="mw-page-title-main">John Gurdon</span> English developmental biologist (born 1933)

Sir John Bertrand Gurdon is a British developmental biologist, best known for his pioneering research in nuclear transplantation and cloning.

<span class="mw-page-title-main">Regenerative medicine</span> Field of medicine involved in regenerating tissues

Regenerative medicine deals with the "process of replacing, engineering or regenerating human or animal cells, tissues or organs to restore or establish normal function". This field holds the promise of engineering damaged tissues and organs by stimulating the body's own repair mechanisms to functionally heal previously irreparable tissues or organs.

Cord blood is blood that remains in the placenta and in the attached umbilical cord after childbirth. Cord blood is collected because it contains stem cells, which can be used to treat hematopoietic and genetic disorders such as cancer. There is growing interest from cell therapeutics companies in developing genetically modified allogenic natural killer cells from umbilical cord blood as an alternative to CAR T cell therapies for rare diseases.

<span class="mw-page-title-main">Francis Peyton Rous</span> American scientist (1879–1970)

Francis Peyton Rous was an American pathologist at the Rockefeller University known for his works in oncoviruses, blood transfusion and physiology of digestion. A medical graduate from the Johns Hopkins University, he was discouraged to become a practicing physician due to severe tuberculosis. After three years of working as an instructor of pathology at the University of Michigan, he became dedicated researcher at the Rockefeller Institute for Medical Research for the rest of his career.

<i>Journal of Experimental Medicine</i> Academic journal

Journal of Experimental Medicine is a monthly peer-reviewed medical journal published by Rockefeller University Press that publishes research papers and commentaries on the physiological, pathological, and molecular mechanisms that encompass the host response to disease. The journal prioritizes studies on intact organisms and has made a commitment to publishing studies on human subjects. Topics covered include immunology, inflammation, infectious disease, hematopoiesis, cancer, stem cells and vascular biology. The journal has no single editor-in-chief, but thirteen academic editors.

<span class="mw-page-title-main">Anthony Atala</span>

Anthony Atala, M.D., is an American bioengineer, urologist, and pediatric surgeon. He is the W.H. Boyce professor of urology, the founding director of the Wake Forest Institute for Regenerative Medicine, and the chair of the Department of Urology at Wake Forest School of Medicine in North Carolina. His work focuses on the science of regenerative medicine: "a practice that aims to refurbish diseased or damaged tissue using the body's own healthy cells".

<span class="mw-page-title-main">Ralph L. Brinster</span> American geneticist

Ralph Lawrence Brinster is an American geneticist, National Medal of Science laureate, and Richard King Mellon Professor of Reproductive Physiology at the School of Veterinary Medicine, University of Pennsylvania.

<i>Bone Marrow Transplantation</i> (journal) Peer-reviewed medical journal published by Nature Research

Bone Marrow Transplantation is a peer-reviewed medical journal covering transplantation of bone marrow in humans. It is published monthly by Nature Research. The scope of the journal includes stem cell biology, transplantation immunology, translational research, and clinical results of specific transplant protocols.

The American Journal of Transplantation is a monthly peer-reviewed medical journal published by Wiley-Blackwell on behalf of the American Society of Transplant Surgeons and the American Society of Transplantation. It covers research on all aspects of organ transplantation. Each issue offers continuing medical education in the form of its Images in Transplantation feature, a case-based approach.

<i>Experimental Neurology</i> Academic journal

Experimental Neurology is a monthly peer-reviewed medical journal that focuses on research in neuroscience concerning mechanisms underlying neurological disorders. The journal focuses on neural development, neuroregeneration, neuroplasticity, and transplantation,. It was established in 1959 and is published by Elsevier. According to the Journal Citation Reports, the journal has a 2020 impact factor of 5.33. In 1997, Experimental Neurology absorbed the quarterly journal Neurodegeneration, which had been established in 1992.

Experimental Biology and Medicine is a monthly peer-reviewed scientific journal that covers experimental biological and medical research. The editor-in-chief is Steven R. Goodman. It was established in 1903 as Proceedings of the Society for Experimental Biology and Medicine and is published by SAGE Publishing on behalf of the Society for Experimental Biology and Medicine. The journal acquired its current name in 2001.

Paul R. Sanberg is an American scientist and inventor. His early work focused on the causes of brain cell death. His recent research has been on methods of repairing damaged brain tissue, and, in tandem with other scientists, demonstrating that stem cells derived from the blood of bone marrow and umbilical cords can be converted to neural cells.

Transplantation is a peer-reviewed medical journal covering transplantation medicine. The editor-in-chief is Jeremy R. Chapman. It was established in 1963 and is published by Wolters Kluwer on behalf of The Transplantation Society and the International Liver Transplantation Society.

<i>Biomarkers in Medicine</i> Academic journal

Biomarkers in Medicine is a monthly peer-reviewed medical journal established in 2007 and published by Future Medicine. The editors-in-chief are Andre Terzic (Mayo Clinic and Scott Waldman. The journal covers all aspects of research on biomarkers.

Regenerative Medicine is a peer-reviewed medical journal covering stem cell research and regenerative medicine. It was established in 2006 and is published by Future Medicine. The editor-in-chief is Chris Mason.

<span class="mw-page-title-main">V. S. Sangwan</span> Indian ophthalmologist

Virender Singh Sangwan is an Indian ophthalmologist and the Dr. Paul Dubord Chair professor and director of the L. V. Prasad Eye Institute, Hyderabad. Known for his research on limbal stem cells, Sangwan is the founder secretary and an adviser of the Uveitis Society of India. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 2006.

The European Journal of Clinical Investigation is a monthly peer-reviewed medical journal covering all aspects of biomedical research. It was established in 1970 as the continuation of Archiv für Klinische Medizin, and is published by John Wiley & Sons on behalf of the European Society for Clinical Investigation, of which it is the official journal. The editor-in-chief is Hendrik Nathoe. According to the Journal Citation Reports, the journal has a 2021 impact factor of 4.686, ranking it 32nd out of 154 journals in the category "Medicine, General & Internal" and 57th out of 133 journals in the category "Medicine, Research & Experimental".

Stem Cells and Development is a biweekly peer-reviewed scientific journal covering cell biology, with a specific focus on biomedical applications of stem cells. It was established in 1992 as the Journal of Hematotherapy, and was renamed the Journal of Hematotherapy & Stem Cell Research in 1999. The journal obtained its current name in 2004. It is published by Mary Ann Liebert, Inc. and the editor-in-chief is Graham C. Parker. According to the Journal Citation Reports, the journal has a 2018 impact factor of 3.147.

References

  1. Sanberg, Paul R.; Lin, Shinn-Zong; Portis, Samantha M. (July 2017). "A New Chapter for Cell Transplantation". Cell Transplantation. 26 (7): 1115. doi:10.1177/0963689717716682. ISSN   0963-6897. PMC   5657741 . PMID   28933209.
  2. "Journals Ranked by Impact: Medicine, Research & Experimental". 2017 Journal Citation Reports. Web of Science (Science ed.). Clarivate Analytics. 2018.